• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53表达在结直肠癌中与DNA倍体的关系及其预后意义

Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.

作者信息

Sun X F, Carstensen J M, Stål O, Zhang H, Nilsson E, Sjödahl R, Nordenskjöld B

机构信息

Department of Oncology, University Hospital of Linköping, Sweden.

出版信息

Virchows Arch A Pathol Anat Histopathol. 1993;423(6):443-8. doi: 10.1007/BF01606533.

DOI:10.1007/BF01606533
PMID:8291217
Abstract

p53 expression, DNA ploidy and S-phase fraction were analysed retrospectively in colorectal adenocarcinomas from 293 patients in whom the long-term outcome was known. The frequency of nuclear p53 staining was increased in non-diploid tumours (42%) when compared with diploid tumours (33%). Cytoplasmic p53 positive tumours were more common in the proximal colon (32%) than in the distal sites (21%). In univariate survival analysis, nuclear p53 and cytoplasmic staining were significantly associated with poor prognosis in patients with Dukes' A-C tumours. The patients showing both nuclear and cytoplasmic p53 staining had the poorest survival and the patients with tumours negative in both the nucleus and cytoplasm showed the best prognosis. The patients with tumours positive in the nucleus alone or in the cytoplasm alone presented an intermediate survival. In multivariate survival analyses, nuclear p53 expression, cytoplasmic p53 expression and DNA ploidy were prognostic indicators independent of Dukes' stage and each other. Further analysis suggested that the prognostic importance of cytoplasmic p53 expression was greater in diploid than in non-diploid tumours. We conclude that nuclear p53 expression, cytoplasmic p53 expression and DNA ploidy provide important prognostic information in colorectal adenocarcinomas.

摘要

对293例已知长期预后的结肠腺癌患者的肿瘤组织进行回顾性分析,检测p53表达、DNA倍体及S期细胞比例。非二倍体肿瘤细胞核p53染色阳性率(42%)高于二倍体肿瘤(33%)。细胞质p53阳性肿瘤在近端结肠(32%)比远端部位(21%)更常见。单因素生存分析显示,核p53和细胞质染色与Dukes' A - C期肿瘤患者的预后不良显著相关。核和细胞质p53染色均阳性的患者生存率最差,而核和细胞质均阴性的患者预后最佳。仅细胞核或仅细胞质p53染色阳性的患者生存率居中。多因素生存分析显示,核p53表达、细胞质p53表达和DNA倍体是独立于Dukes分期且相互独立的预后指标。进一步分析表明,细胞质p53表达在二倍体肿瘤中的预后重要性高于非二倍体肿瘤。我们得出结论,核p53表达、细胞质p53表达和DNA倍体为结肠腺癌提供了重要的预后信息。

相似文献

1
Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.p53表达在结直肠癌中与DNA倍体的关系及其预后意义
Virchows Arch A Pathol Anat Histopathol. 1993;423(6):443-8. doi: 10.1007/BF01606533.
2
c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma.结直肠癌中c-erbB-2癌蛋白与DNA倍体及预后的关系
APMIS. 1995 Apr;103(4):309-15. doi: 10.1111/j.1699-0463.1995.tb01112.x.
3
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.细胞质p53癌蛋白在结直肠癌中的预后意义。
Lancet. 1992 Dec 5;340(8832):1369-73. doi: 10.1016/0140-6736(92)92558-w.
4
Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.p53蛋白的细胞质积聚:结直肠癌的一个独立预后指标。
J Natl Cancer Inst. 1994 May 4;86(9):681-7. doi: 10.1093/jnci/86.9.681.
5
ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.ras p21在结直肠癌中的表达与DNA倍体、S期分数及预后的关系
Eur J Cancer. 1991;27(12):1646-9. doi: 10.1016/0277-5379(91)90437-i.
6
Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.p53核与胞质过表达在左右侧结肠腺癌中的预后意义
Eur J Cancer. 1996 Oct;32A(11):1963-7. doi: 10.1016/0959-8049(96)00205-5.
7
Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.Ras基因的过表达是结肠腺癌的一个独立预后因素。
APMIS. 1998 Jun;106(6):657-64.
8
Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.评估四种抗体检测p53蛋白对预测结直肠癌临床病理及预后意义的作用。
Clin Cancer Res. 1999 Dec;5(12):4126-32.
9
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.p53在结直肠癌中的表达:与肿瘤类型、DNA倍体模式及短期生存的关系
Am J Clin Pathol. 1996 May;105(5):604-12. doi: 10.1093/ajcp/105.5.604.
10
Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.结直肠癌中倍体的独立预后价值。一项使用图像细胞术的前瞻性研究。
Cancer. 1990 Sep 15;66(6):1168-75. doi: 10.1002/1097-0142(19900915)66:6<1168::aid-cncr2820660616>3.0.co;2-i.

引用本文的文献

1
Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.肿瘤基质中的巨噬细胞浸润与结直肠癌中肿瘤细胞CD163的表达相关。
Cancer Microenviron. 2014 Aug;7(1-2):61-9. doi: 10.1007/s12307-014-0145-7. Epub 2014 Apr 28.
2
p53 selectively regulates developmental apoptosis of rod photoreceptors.p53 选择性调节杆状光感受器的发育性细胞凋亡。
PLoS One. 2013 Jun 20;8(6):e67381. doi: 10.1371/journal.pone.0067381. Print 2013.
3
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.

本文引用的文献

1
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.p53过表达和c-Ki-ras基因突变在结直肠癌中的预后价值
Gastroenterology. 1993 Jan;104(1):57-64. doi: 10.1016/0016-5085(93)90835-z.
2
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected].结直肠癌等位基因缺失的临床和病理关联[已校正]
JAMA. 1989 Jun 2;261(21):3099-103. doi: 10.1001/jama.261.21.3099.
3
Multiple genetic alterations in distal and proximal colorectal cancer.远端和近端结直肠癌中的多种基因改变。
p63的异常细胞质表达与前列腺癌死亡率
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):595-600. doi: 10.1158/1055-9965.EPI-08-0785. Epub 2009 Jan 20.
4
Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance.免疫组织化学检测结直肠癌中p53和mdm-2癌蛋白表达:预后意义
Clin Mol Pathol. 1995 Feb;48(1):M12-6. doi: 10.1136/mp.48.1.m12.
5
Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers.结直肠癌中肿瘤炎症浸润及坏死与微卫星不稳定性的关系
World J Gastroenterol. 2005 Apr 14;11(14):2179-83. doi: 10.3748/wjg.v11.i14.2179.
6
Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.结直肠癌患者循环中p53抗体:与临床病理特征及生存的关系
Dig Dis Sci. 2000 Jan;45(1):122-8. doi: 10.1023/a:1005473729976.
7
p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?p53和Rb1蛋白表达:它们对结直肠癌的预后评估有帮助吗?
Br J Cancer. 1997;75(1):87-93. doi: 10.1038/bjc.1997.14.
8
Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia.p53蛋白表达与结直肠肿瘤细胞凋亡发生率的相关性
Virchows Arch. 1995;427(1):27-32. doi: 10.1007/BF00203734.
9
Risk factors related to liver metastasis in colorectal carcinoma: a multivariate analysis of clinicopathologic and immunohistochemical variables.结直肠癌肝转移相关危险因素:临床病理及免疫组化变量的多因素分析
Jpn J Cancer Res. 1994 Dec;85(12):1280-7. doi: 10.1111/j.1349-7006.1994.tb02941.x.
Lancet. 1989 Aug 12;2(8659):353-6. doi: 10.1016/s0140-6736(89)90537-0.
4
Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry.通过流式细胞术同时监测大肠腺癌的P53蛋白和DNA含量。
Int J Cancer. 1990 Mar 15;45(3):450-6. doi: 10.1002/ijc.2910450313.
5
p53: oncogene or anti-oncogene?p53:致癌基因还是抗癌基因?
Genes Dev. 1990 Jan;4(1):1-8. doi: 10.1101/gad.4.1.1.
6
p53 in the diagnosis of human neoplasia.
J Natl Cancer Inst. 1991 Jul 17;83(14):980-1. doi: 10.1093/jnci/83.14.980.
7
p53 in colorectal cancer: clinicopathological correlation and prognostic significance.p53在结直肠癌中的临床病理相关性及预后意义
Br J Cancer. 1991 Feb;63(2):317-9. doi: 10.1038/bjc.1991.74.
8
Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.人类结直肠癌中p53基因杂合性缺失及p53蛋白表达情况
Cancer Res. 1991 Aug 15;51(16):4436-42.
9
ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.ras p21在结直肠癌中的表达与DNA倍体、S期分数及预后的关系
Eur J Cancer. 1991;27(12):1646-9. doi: 10.1016/0277-5379(91)90437-i.
10
Causes, relevant mechanisms, and prevention of large bowel cancer.大肠癌的病因、相关机制及预防
Semin Oncol. 1991 Aug;18(4):316-36.